npj Vaccines (Feb 2021)

Immunofocusing and enhancing autologous Tier-2 HIV-1 neutralization by displaying Env trimers on two-component protein nanoparticles

  • Philip J. M. Brouwer,
  • Aleksandar Antanasijevic,
  • Marlon de Gast,
  • Joel D. Allen,
  • Tom P. L. Bijl,
  • Anila Yasmeen,
  • Rashmi Ravichandran,
  • Judith A. Burger,
  • Gabriel Ozorowski,
  • Jonathan L. Torres,
  • Celia LaBranche,
  • David C. Montefiori,
  • Rajesh P. Ringe,
  • Marit J. van Gils,
  • John P. Moore,
  • Per Johan Klasse,
  • Max Crispin,
  • Neil P. King,
  • Andrew B. Ward,
  • Rogier W. Sanders

DOI
https://doi.org/10.1038/s41541-021-00285-9
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 14

Abstract

Read online

Abstract The HIV-1 envelope glycoprotein trimer is poorly immunogenic because it is covered by a dense glycan shield. As a result, recombinant Env glycoproteins generally elicit inadequate antibody levels that neutralize clinically relevant, neutralization-resistant (Tier-2) HIV-1 strains. Multivalent antigen presentation on nanoparticles is an established strategy to increase vaccine-driven immune responses. However, due to nanoparticle instability in vivo, the display of non-native Env structures, and the inaccessibility of many neutralizing antibody (NAb) epitopes, the effects of nanoparticle display are generally modest for Env trimers. Here, we generate two-component self-assembling protein nanoparticles presenting twenty SOSIP trimers of the clade C Tier-2 genotype 16055. We show in a rabbit immunization study that these nanoparticles induce 60-fold higher autologous Tier-2 NAb titers than the corresponding SOSIP trimers. Epitope mapping studies reveal that the presentation of 16055 SOSIP trimers on these nanoparticle focuses antibody responses to an immunodominant apical epitope. Thus, these nanoparticles are a promising platform to improve the immunogenicity of Env trimers with apex-proximate NAb epitopes.